Nivolumab and Ipilimumab in Advanced Melanoma

被引：36
|
作者：
Ryu, Hyewon [1 ]
Lee, Hyo Jin [1 ]
机构：
[1] Chungnam Natl Univ, Coll Med, Daejeon, South Korea
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 25期
关键词：
D O I：
10.1056/NEJMc1714339
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2503 / 2503
页数：1
相关论文
共 50 条
  • [31] Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Chapman, Paul B.
    Jayaprakasam, Vetri Sudar
    Panageas, Katherine S.
    Callahan, Margaret
    Postow, Michael A.
    Shoushtari, Alexander N.
    Wolchok, Jedd D.
    Warner, Allison Betof
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [32] Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in locally advanced or oligometastatic melanoma: Preliminary results
    Cocorocchio, E.
    Pala, L.
    Nezi, L.
    Manzo, T.
    Mazzarella, L.
    Fiorenza, L.
    Gandini, S.
    Conforti, F.
    Mazzarol, G.
    Queirolo, P.
    Pennacchioli, E.
    Orsolini, G. M.
    Fierro, M. T.
    Ribero, S.
    Senetta, R.
    Fava, P.
    Picciotto, F.
    Caliendo, V.
    Quaglino, P.
    Ferrucci, P. F.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S765 - S766
  • [33] Nivolumab plus Ipilimumab in Advanced Melanoma (vol 369, pg 122, 2013)
    Ribas, Antoni
    Hodi, F. Stephen
    Callahan, Margaret
    Konto, Cyril
    Wolchok, Jedd
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [34] Real-world outcomes of ipilimumab plus nivolumab for advanced melanoma in the Netherlands
    van Zeijl, M. C. T.
    Wouters, M. W. J. M.
    van den Eertwegh, A. J. M.
    de Wreede, L. C.
    Aarts, M. J. B.
    van Akkooi, A. C. J.
    Van den Berkmortel, F. W. P. J.
    de Groot, J. W.
    Boers-Sonderen, M. J.
    van der Hoeven, J. J. M.
    Hospers, G. A. P.
    Kapiteijn, E.
    Piersma, D.
    van Rijn, R. S.
    Suijkerbuijk, K. P. M.
    Ten Tije, A. J.
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Haanen, J. B. A. G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [35] Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma
    Takahashi, Akira
    Namikawa, Kenjiro
    Ogata, Dai
    Jinnai, Shunichi
    Nakano, Eiji
    Yamazaki, Naoya
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (04): : 525 - 535
  • [36] Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab
    Ma, Vincent T.
    Perera, Alahendra A. Chamila
    Sun, Yilun
    Sitto, Merna
    Waninger, Jessica J.
    Warrier, Govind
    Green, Michael D.
    Fecher, Leslie A.
    Lao, Christopher D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Ipilimumab, nivolumab and tocilizumab as first-line therapy for advanced melanoma.
    Mehmi, Inderjit
    Hamid, Omid
    Hodi, F. Stephen
    Vassalo, Melinda
    Malatyali, Saundra
    Krishnarajapet, Swathi
    O'Donnell, Nan
    Castrence, Angeli
    Lim, Eunice
    Gormley, Jill
    Weber, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] COST EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN ENGLAND
    Lee, D.
    Amadi, A.
    Sabater, J.
    Ellis, J.
    Johnson, H.
    Roskell, N.
    Meng, Y.
    Patterson, K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A731 - A731
  • [39] A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
    Postow, Michael A.
    Knox, Susan J.
    Goldman, Debra A.
    Elhanati, Yuval
    Mavinkurve, Vikram
    Wong, Phillip
    Halpenny, Darragh
    Reddy, Sunil K.
    Vado, Kenya
    McCabe, Danielle
    Ramirez, Kristen Aufiero
    Macri, Mary
    Schwarzenberger, Paul
    Ricciardi, Toni
    Ryan, Aileen
    Venhaus, Ralph
    Momtaz, Parisa
    Shoushtari, Alexander N.
    Callahan, Margaret K.
    Chapman, Paul B.
    Wolchok, Jedd D.
    Subrahmanyam, Priyanka B.
    Maecker, Holden T.
    Panageas, Katherine S.
    Barker, Christopher A.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3193 - 3201
  • [40] Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome.
    Cocorocchio, Emilia
    Gandini, Sara
    Nezi, Luigi
    Manzo, Teresa
    Mazzarella, Luca
    Barberis, Massimo
    Lanfrancone, Luisa
    Pala, Laura
    Conforti, Fabio
    Pennacchioli, Elisabetta
    Orsolini, Gianmarco
    Fierro, Maria Teresa
    Quaglino, Pietro
    Senetta, Rebecca
    Caliendo, Virginia
    Stucchi, Concetta Riviello Sara
    Macandog, Angeli Dominique
    Frige, Gianmaria
    Ferrucci, Pier Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345